When Guidelines Outpace Capacity: A Systems Analysis of Genome-First Testing in Neurodevelopmental Disorders
Abstract Purpose Clinical guidelines now recommend exome or genome sequencing as first-line testing for autism spectrum disorder (ASD), intellectual disability (ID), and global developmental delay (GDD). However, the systems-level capacity needed to implement genome-first testing at scale remains poorly characterized. We quantified institutional demand for genomic testing among neurodevelopmental patients and compared it with available genetics clinic capacity. Methods We conducted a retrospective EHR review of all patients scheduled within a large Division of Developmental and Behavioral Pediatrics (DDBP) over four weeks (January 26–February 20, 2026). Patients were eligible if they had ASD, ID, and/or GDD and had not previously undergone exome or genome sequencing. We extracted demographics, prior genetic testing, and Social Deprivation Index (SDI) scores, and quantified available general and neurodevelopmental genetics clinic appointment slots during the same interval to assess workforce capacity. Results Of 473 eligible individuals, 72% were test-naïve. Most were male (72%) and Medicaid-insured (62%), with a mean SDI score of 54 (SD 26). Only 240 genetics clinic slots were available institution-wide during the same period, roughly half the eligible volume, revealing a substantial gap between guideline-recommended eligibility and specialist capacity. Conclusion At our institution, genome-first testing guidelines have outpaced existing genetics workforce capacity. These findings motivate an ongoing systems-redesign effort; alternative consent and testing-initiation workflows embedded within DDBP clinics may help bridge the evidence-to-practice gap and support equitable access to genomic medicine.
Authors
- Amelle Shillington (ORCID: https://orcid.org/0000-0002-7447-8117)
- Rachel Doberstein (ORCID: https://orcid.org/0009-0001-3005-3969)
- Cassandra Conrad (ORCID: https://orcid.org/0000-0002-7561-7182)
- Jeremy Brown
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Cincinnati (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-10961999/v1
- Primary Topic
- Genomics and Rare Diseases
- Type
- preprint
Funders
- Cincinnati Children's Hospital Medical Center
- National Institutes of Health